As of September 2026, more than 4,000 gastrointestinal-injury cases remain pending in MDL No. 3094 before Judge Karen S. Marston in the Eastern District of Pennsylvania. The court held live Daubert/Rule 702 hearings from September 10 to 18, 2026, on the scientific and medical testimony each side plans to use at trial — a key step before any bellwether case can be scheduled. No bellwether trial date has been set yet, and no global settlement or claim form has been announced. Separately, vision-loss claims alleging NAION from GLP-1 drugs are now proceeding in their own MDL, No. 3163, established in December 2025 and still in early stages before the same judge.
Last updated: September 2026
Yes, there is an active lawsuit against Ozempic, and it has grown into one of the largest pharmaceutical mass tort cases in the United States. If you took Ozempic, Wegovy, or any semaglutide-based drug and suffered serious stomach or gastrointestinal injuries, you may have a legal claim right now.
Thousands of patients have already filed cases in federal court. The litigation is centralized in Pennsylvania and moving toward trial-phase decisions in 2026.
This guide covers everything: what the lawsuits allege, who qualifies, how compensation works, what the 2026 timeline looks like, and how to get your claim started before deadlines pass.
One number tells the story fast. As of early 2026, more than 10,000 individual cases are pending inside the federal MDL docket against the makers of Ozempic and Wegovy.
Is There a Lawsuit Against Ozempic?
Yes, there is a lawsuit against Ozempic, and it has been building since 2023 with serious legal force behind it.
Patients across the country sued Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic. The core allegation is straightforward: the company knew or should have known that its drug caused severe gastrointestinal injuries, and it failed to adequately warn patients and doctors about that risk.
The lawsuits are not about whether Ozempic works. It does lower blood sugar and help with weight loss. The issue is that some patients developed paralyzing, life-altering stomach conditions that were not clearly disclosed on the label.
By late 2023, federal courts consolidated these cases into a single MDL docket. By 2026, that docket has grown significantly and is approaching critical legal milestones.
| Key Facts | Details |
|---|---|
| Drug at Center of Lawsuit | Ozempic (semaglutide) |
| Manufacturer Being Sued | Novo Nordisk |
| Primary Injury Alleged | Gastroparesis, stomach paralysis, bowel obstruction |
| Court Location | Eastern District of Pennsylvania |
| MDL Number | MDL No. 3094 |
| Cases Filed as of 2026 | More than 10,000 individual cases |
The cases are not going away. If anything, more patients are joining the litigation as awareness of Ozempic’s gastrointestinal risks grows.
Is There a Class Action Lawsuit Against Ozempic?
There is not a traditional class action lawsuit against Ozempic in the way most people picture one.
What exists instead is a mass tort, specifically an MDL, which stands for multidistrict litigation. This is different from a class action in important ways, and that difference directly affects how much money individual claimants can receive.
In a class action, all plaintiffs receive roughly the same settlement amount. In an MDL mass tort, each case is evaluated individually. That means your specific injuries, your medical records, your treatment costs, and your personal suffering all factor into your individual payout.
Some plaintiffs’ attorneys have filed or sought class action status for certain consumer protection claims related to Ozempic, particularly around misleading marketing. Those claims are separate from the personal injury cases in the MDL.
| Structure | Class Action | MDL Mass Tort |
|---|---|---|
| Cases treated | As one group | Individually |
| Payout | Same for all | Varies by injury severity |
| Your control | Low | Higher |
| Ozempic status | Limited consumer claims | Main litigation track |
The bottom line: the primary Ozempic lawsuit is a mass tort, not a class action. That is actually better for seriously injured patients.
Is There an Ozempic Lawsuit You Can Actually Join?
Yes, there is an Ozempic lawsuit you can join right now if you meet the basic eligibility criteria.
The MDL is open to new plaintiffs. Cases are still being accepted. Patients who took Ozempic, Wegovy, or other semaglutide-based GLP-1 drugs and suffered documented gastrointestinal injuries can file an individual lawsuit that gets consolidated into the MDL.
Joining does not mean going to trial by yourself. Your case joins the large MDL, which means it benefits from shared discovery, shared expert witnesses, and the leverage that comes from being part of a massive coordinated litigation.
Think of it like a freight train. Your individual case is one car on that train. The MDL provides the engine.
To get your case on the train, you need to have taken a qualifying drug, suffered a qualifying injury, and have medical documentation of both. An MDL-registered attorney files your complaint in federal court and it gets transferred to the Eastern District of Pennsylvania.
Important: Cases filed in 2026 are still being accepted, but the window is not unlimited. Statutes of limitations vary by state and circumstances.
Ozempic Lawsuit 2026 Update: Where Things Stand Right Now
The Ozempic lawsuit in 2026 is at a pivotal stage, with bellwether trials on the horizon and settlement discussions likely intensifying.
As of early 2026, MDL No. 3094 in the Eastern District of Pennsylvania is the central hub for all federal Ozempic injury cases. The MDL court has been managing discovery, expert witness preparation, and selection of bellwether trial cases.
Bellwether trials are the first few cases to go to trial in an MDL. They function as test cases. Their verdicts signal to both sides what the broader litigation is worth, which drives settlement negotiations.
2026 Ozempic Lawsuit Timeline Snapshot:
| Phase | Status in 2026 |
|---|---|
| MDL Consolidation | Complete, cases being managed in E.D. Pennsylvania |
| Discovery | Advanced stage, expert depositions ongoing |
| Bellwether Selection | Cases selected, trial preparation underway |
| First Bellwether Trials | Expected mid-to-late 2026 |
| Global Settlement Talks | Anticipated to accelerate after first verdicts |
| Statute of Limitations Risk | Active, varies by state (2 to 3 years from injury discovery) |
If early bellwether verdicts favor plaintiffs, expect Novo Nordisk to move quickly toward a global settlement framework. That is the pattern in nearly every major pharmaceutical MDL.
Key Takeaway: The Ozempic MDL is active, growing, and approaching trial-phase activity in 2026, which makes this the most important year yet for potential claimants.
The Ozempic Gastroparesis Lawsuit Explained
The Ozempic gastroparesis lawsuit is the largest and most established category of injury claims in this litigation.
Gastroparesis means stomach paralysis. The stomach stops moving food through normally. Instead of digesting properly, food sits in the stomach for hours or even days. The result is severe, persistent nausea, vomiting, bloating, and malnutrition.
Plaintiffs claim that Ozempic, which works by slowing gastric emptying as part of its mechanism, caused some patients to develop permanent or severe gastroparesis. The drug is supposed to slow digestion slightly. In certain patients, it allegedly caused that slowing to become a permanent, disabling condition.
The legal theory is failure to warn. Plaintiffs argue that Novo Nordisk did not adequately disclose the risk of developing prolonged or permanent gastroparesis, even though the company had data suggesting the risk existed.
| Gastroparesis Claim Details | Information |
|---|---|
| Condition | Gastroparesis (stomach paralysis) |
| Drug mechanism connection | GLP-1 slows gastric emptying; alleged to cause permanent slowing |
| Legal theory | Failure to warn, product liability |
| Types of harm claimed | Hospitalization, feeding tubes, surgical intervention, lost income |
| Typical patient profile | Used Ozempic for weight loss or Type 2 diabetes, no pre-existing gastroparesis |
Gastroparesis claims are the most well-documented injury category in the MDL. Patients with clear pre-drug and post-drug medical records showing new-onset gastroparesis are considered strong plaintiffs.
Ozempic Stomach Paralysis Lawsuit: What Patients Are Claiming
Stomach paralysis is the plain-English term for what many Ozempic lawsuit plaintiffs say happened to them, and the claims go beyond just stomach discomfort.
Patients describe situations where they could not keep food or water down for weeks. Some required hospitalization for dehydration and malnutrition. Others needed feeding tubes. Some underwent surgeries to address complications. A smaller number experienced life-threatening events including pulmonary aspiration, which happens when stomach contents enter the lungs.
The lawsuits allege that these injuries were not minor or temporary. For many plaintiffs, the stomach paralysis either became a chronic condition or required ongoing medical management even after stopping Ozempic.
What makes these claims legally strong is the temporal link. Patients who had no stomach problems before starting Ozempic and then developed severe paralytic symptoms shortly after starting the drug have a clear narrative for a jury.
Injuries Cited in Stomach Paralysis Claims:
- Severe and persistent vomiting lasting weeks or months
- Hospitalization for dehydration or malnutrition
- Requirement of nasogastric feeding tubes
- Surgical interventions including gastric stimulators
- Pulmonary aspiration events
- Permanent dietary restrictions and lifestyle limitations
- Psychological harm from chronic illness
The severity of these injuries is a central argument for why settlement values in this MDL are expected to be significant.
Ozempic Side Effects Lawsuit: Which Injuries Qualify?
Not every Ozempic side effect qualifies for a lawsuit, and understanding which injuries meet the legal threshold matters before you invest time filing a claim.
Mild nausea, temporary vomiting, or brief diarrhea that resolved on its own generally will not support a lawsuit. The bar for litigation is serious, documented, and diagnosable medical harm.
The injuries courts and plaintiffs’ attorneys are focusing on in 2026 fall into specific categories. These are the injuries with established medical documentation, expert support, and legal precedent developing inside the MDL.
Qualifying Ozempic Side Effects for Lawsuit Purposes:
| Injury | Qualifying Factors |
|---|---|
| Gastroparesis | Diagnosed by gastric emptying study; new onset after drug use |
| Bowel obstruction | Hospitalization required; no prior bowel condition |
| Ileus (intestinal paralysis) | Documented in hospital records; linked to drug timeline |
| Pulmonary aspiration | During surgery or medical procedure; documented in records |
| Cyclic vomiting syndrome | Diagnosed by physician; onset tied to drug use |
| Stomach paralysis (general) | Imaging or motility studies confirming delayed emptying |
Injuries that are not currently the focus of MDL litigation include general weight regain, headaches, fatigue, or mild injection-site reactions. Those do not meet the severity threshold.
Key Takeaway: Gastroparesis, bowel obstruction, and stomach paralysis are the qualifying injuries driving the Ozempic lawsuit, while minor or temporary side effects do not meet the legal threshold for filing.
Who Qualifies for the Ozempic Lawsuit?
You qualify for the Ozempic lawsuit if you took a GLP-1 drug, suffered a serious documented gastrointestinal injury, and can show a connection between the two.
The drug does not have to be Ozempic specifically. The MDL also covers Wegovy, which uses the same semaglutide ingredient. Cases involving Mounjaro and Zepbound, Eli Lilly’s competing drugs, are also being evaluated in related litigation.
Your injury needs to be diagnosed and documented in medical records. A personal belief that Ozempic made you sick is not sufficient on its own. You need a doctor’s diagnosis, ideally with objective test results confirming the condition.
Basic Qualification Checklist:
- You took Ozempic, Wegovy, or another GLP-1 drug (semaglutide or tirzepatide)
- You were diagnosed with gastroparesis, bowel obstruction, ileus, or another qualifying injury
- Your injury occurred after starting the drug (not a pre-existing condition)
- You have medical records documenting the diagnosis and treatment
- You did not previously suffer from the same condition before taking the drug
- Your injury required medical treatment beyond routine management
The strength of your case increases with the severity of your injury, the quality of your documentation, and the clarity of the timeline between drug use and symptom onset.
Ozempic Lawsuit Eligibility: The Full Breakdown
Eligibility for the Ozempic lawsuit comes down to four factors: the drug, the diagnosis, the timeline, and the documentation.
Each factor can make or break a case. Strong cases have all four clearly established. Weaker cases may face challenges if one element is missing or ambiguous.
Factor 1: The Drug
You must have taken a qualifying GLP-1 drug. Ozempic and Wegovy are the primary drugs. Both contain semaglutide. Some cases involving tirzepatide drugs like Mounjaro are being evaluated separately.
Factor 2: The Diagnosis
You need a formal medical diagnosis of a qualifying injury. Gastroparesis diagnosed via gastric emptying study is the gold standard. Bowel obstruction, ileus, and cyclic vomiting syndrome are also qualifying diagnoses.
Factor 3: The Timeline
Your injury must have developed after you started taking the drug. Ideally, you had no prior history of the same condition. Plaintiffs with clean medical histories before Ozempic use are the strongest candidates.
Factor 4: The Documentation
| Document Type | Why It Matters |
|---|---|
| Prescription records | Proves you took the drug |
| Medical diagnosis records | Proves the injury exists |
| Hospital/ER records | Shows severity and treatment required |
| Gastric emptying study results | Objective proof of gastroparesis |
| Doctor’s notes pre-drug | Shows no prior condition existed |
| Billing and insurance records | Demonstrates financial harm |
Even if you are unsure whether you qualify, an initial case evaluation with an MDL-registered attorney is typically free and can answer the question definitively.
Ozempic Class Action vs Mass Tort: What Is the Difference?
The Ozempic class action versus mass tort distinction matters enormously because it directly affects how much money individual claimants can receive.
A class action groups all plaintiffs together. The total settlement gets divided among the entire group. If 100,000 people are in a class action and the settlement is $100 million, each person gets roughly $1,000 before attorney fees. The payout is equal regardless of how seriously anyone was hurt.
A mass tort, which is what the Ozempic litigation is, treats each case individually. Your compensation reflects your specific injuries, your medical costs, your lost wages, and your personal pain and suffering. A plaintiff who spent three months in the hospital receives significantly more than someone who experienced two weeks of vomiting.
For seriously injured Ozempic patients, the mass tort structure is the better option.
| Comparison Factor | Class Action | Mass Tort / MDL |
|---|---|---|
| How plaintiffs are treated | As a group | As individuals |
| Payout basis | Equal share of total | Based on individual injury |
| Good for minor injuries | Yes | Less efficient |
| Good for serious injuries | No | Yes |
| Ozempic lawsuit type | Not primary track | Primary track |
| Settlement negotiation | One deal for everyone | Global + individual |
The Ozempic litigation may eventually produce a global settlement framework. But individual payouts will still reflect individual injury severity, not a flat equal-share distribution.
The Ozempic MDL Lawsuit: How the Federal Case Works
The Ozempic MDL lawsuit is the formal legal structure organizing thousands of individual injury cases into one coordinated federal proceeding.
MDL stands for multidistrict litigation. When many lawsuits against the same defendant over the same product pile up across different federal courts, the Judicial Panel on Multidistrict Litigation (JPML) can consolidate them into one court for pretrial proceedings. That is what happened with Ozempic.
MDL No. 3094 is centralized in the United States District Court for the Eastern District of Pennsylvania. All federal Ozempic injury cases get transferred to this court for coordinated discovery, expert witness proceedings, and bellwether trial management.
Here is the practical reality for individual claimants: your case is filed, gets consolidated into the MDL, benefits from all the shared work done by the MDL leadership, and eventually either goes to trial as a bellwether case or is resolved through settlement.
How the MDL Works, Step by Step:
- Plaintiff files individual lawsuit in federal court
- JPML transfers the case to the Eastern District of Pennsylvania
- Case is consolidated into MDL No. 3094
- Shared discovery occurs across all cases
- Expert witnesses are designated and deposed collectively
- Bellwether cases are selected and tried
- Settlement negotiations intensify based on trial results
- Individual cases resolve through negotiated settlements or trial
The MDL structure benefits plaintiffs by pooling legal resources. Small-firm attorneys and their clients get access to the same expert witnesses and discovery that a large firm would have on its own.
Key Takeaway: The Ozempic MDL in Pennsylvania is the legal engine driving all federal injury claims, and understanding how it works helps claimants set realistic expectations for timelines and outcomes.
Ozempic Lawsuit Bellwether Trials: What They Mean for Your Case
Bellwether trials are the first individual Ozempic cases to go before a jury, and their results will shape the entire litigation’s future.
The word “bellwether” comes from farming. A bellwether sheep leads the flock. In MDL litigation, bellwether cases lead the way by testing legal theories, establishing what evidence a jury finds compelling, and signaling what a case is worth.
The MDL court selects a handful of cases that represent the broader pool of plaintiffs. These go to trial first. If plaintiffs win big, Novo Nordisk has strong incentive to settle the thousands of remaining cases rather than risk repeated jury verdicts against them.
If the defense wins the early bellwether trials, the dynamics shift. Settlement offers may shrink, and some weaker cases may be dismissed. This is why the 2026 bellwether schedule is the most watched development in the entire Ozempic litigation.
Why Bellwether Results Matter to You:
| Bellwether Outcome | Effect on Your Case |
|---|---|
| Large plaintiff verdict | Novo Nordisk under pressure to settle; payouts likely rise |
| Defense verdict | Settlement values may decrease; weaker cases face dismissal |
| Mixed verdicts | Litigation continues; negotiations proceed case by case |
| Settlement before trial | Global resolution framework may emerge quickly |
Even if your case is not selected as a bellwether, the outcome of those trials directly affects what your case settles for. Think of it as your case riding the wave that the bellwether creates.
Novo Nordisk Lawsuit Ozempic: The Company’s Role and Response
Novo Nordisk is the primary defendant in the Ozempic lawsuit, and the company has consistently defended its drug while making limited label updates under FDA pressure.
Novo Nordisk is a Danish pharmaceutical company and one of the largest in the world. Ozempic generated billions in annual revenue, making it one of the company’s most valuable products. The financial stakes for defending this litigation are enormous.
The company’s legal position, broadly stated, is that Ozempic is safe and effective, that it has always provided appropriate warnings, and that the gastrointestinal side effects plaintiffs describe are either not caused by the drug or are adequately disclosed in the labeling.
In 2023, the FDA required Novo Nordisk to update Ozempic’s label to add warnings about the risk of ileus (intestinal obstruction). Plaintiffs’ attorneys argue this is evidence that the company knew about serious gastrointestinal risks and had not previously disclosed them adequately.
Novo Nordisk’s Legal Response at a Glance:
- Denies that Ozempic causes permanent gastroparesis
- Argues existing label warnings were sufficient
- Points to FDA approval as evidence of safety
- Has not announced any settlement fund or global resolution as of early 2026
- Is actively defending cases in MDL discovery proceedings
The company’s response is typical of large pharmaceutical defendants in mass tort litigation. They rarely settle early. The pressure builds as bellwether trials approach.
Ozempic Lawsuit Settlement Amount: What Are the Numbers?
No global Ozempic lawsuit settlement amount has been announced as of 2026, but estimates based on comparable pharmaceutical MDL cases give a realistic picture of what claims might be worth.
The pharmaceutical mass tort history provides useful benchmarks. Zantac litigation produced individual settlements ranging from tens of thousands to several hundred thousand dollars depending on injury severity. Invokana litigation, another diabetes drug MDL, produced settlements averaging in the low six figures for qualifying plaintiffs.
Ozempic cases are expected to fall in a similar range, with significant variation based on injury severity, medical costs, and individual circumstances.
Estimated Ozempic Settlement Tiers (Based on MDL Comparables):
| Injury Tier | Description | Estimated Settlement Range |
|---|---|---|
| Tier 1 (Mild) | Short-term gastroparesis, resolved with treatment | $25,000 to $75,000 |
| Tier 2 (Moderate) | Hospitalization required, partial recovery | $75,000 to $250,000 |
| Tier 3 (Severe) | Long-term or permanent gastroparesis, feeding tube, surgery | $250,000 to $600,000+ |
| Tier 4 (Catastrophic) | Life-threatening events, permanent disability, major surgeries | $600,000 to $1,000,000+ |
These are estimates. No settlement matrix has been officially established. Actual payouts will depend on bellwether trial results, Novo Nordisk’s negotiating position, and the strength of individual cases.
Key Takeaway: Individual Ozempic lawsuit settlements could range from $25,000 to over $1 million depending on injury severity, with the most catastrophic cases commanding the highest amounts.
Ozempic Lawsuit Compensation: What You Could Realistically Receive
Ozempic lawsuit compensation covers multiple categories of harm, not just medical bills, and understanding all the components helps you assess the full value of a potential claim.
Medical costs are the foundation. Hospital stays, diagnostic testing, specialist visits, medications, feeding tubes, and surgical procedures all count. But the compensation picture is broader than just out-of-pocket costs.
Lost wages matter significantly. If severe gastroparesis kept you out of work for weeks or months, or permanently changed your ability to work, that income loss is recoverable. For high-income earners or self-employed individuals, this number alone can be substantial.
Pain and suffering damages are often the largest component in pharmaceutical injury cases. These are non-economic damages that compensate for physical pain, emotional distress, reduced quality of life, and the ongoing burden of living with a chronic condition.
Categories of Compensation in Ozempic Cases:
| Compensation Category | What It Covers |
|---|---|
| Medical expenses (past) | Bills already incurred for treatment |
| Medical expenses (future) | Ongoing or future treatment costs |
| Lost wages (past) | Income lost during illness and recovery |
| Lost earning capacity | Reduced ability to earn in the future |
| Pain and suffering | Physical pain, emotional distress, daily hardship |
| Loss of enjoyment of life | Activities you can no longer do |
| Punitive damages | Possible if Novo Nordisk’s conduct is found egregious |
Punitive damages are not guaranteed and are typically reserved for cases where a manufacturer is found to have acted with reckless disregard for patient safety. They can multiply the total award significantly if awarded.
How to File an Ozempic Lawsuit in 2026
Filing an Ozempic lawsuit in 2026 starts with one step: finding an attorney who handles pharmaceutical mass tort cases and has MDL experience.
Do not file on your own. MDL litigation is not like small claims court. It requires proper case evaluation, medical record collection, expert witness support, and formal filing with the MDL court in Pennsylvania. Attempting this alone would almost certainly result in your case being rejected or dismissed.
The process with an attorney is straightforward. Most MDL-registered law firms handle Ozempic cases on a contingency fee basis. That means you pay nothing upfront. The attorney takes a percentage of your settlement or award only if you win.
How the Filing Process Works:
- Free case evaluation: Attorney reviews your drug use history and injuries
- Medical records collection: Attorney gathers prescriptions, hospital records, diagnostic results
- Complaint drafting: Attorney prepares your individual lawsuit document
- Federal filing: Complaint is filed in federal court
- MDL transfer: Your case is transferred to the Eastern District of Pennsylvania
- Discovery participation: Your case contributes to and benefits from MDL-wide discovery
- Settlement or trial: Your case resolves either through negotiated settlement or at trial
The entire process from evaluation to filing typically takes two to eight weeks. The settlement or trial resolution takes considerably longer, depending on where the MDL stands.
Be thorough about gathering your medical records. Prescription records from your pharmacy. Hospital discharge summaries. Gastric emptying study results. Any imaging that shows stomach or intestinal abnormalities. These documents are the backbone of your case.
Ozempic Lawsuit Filing Deadline 2026: Do Not Miss This
The Ozempic lawsuit filing deadline in 2026 is not a single national date. It depends on your state’s statute of limitations, which varies and starts running from the date you knew or should have known your injury was connected to the drug.
Most states have a two-year or three-year statute of limitations for personal injury claims. The clock typically starts when you were diagnosed with the injury or when you reasonably should have connected the injury to Ozempic, not necessarily when you first took the drug.
This matters because some patients took Ozempic years ago but only recently received a gastroparesis diagnosis. The clock may have started relatively recently for those individuals. Others who were diagnosed in 2022 or 2023 may be closer to or past their deadline depending on their state.
Statute of Limitations by Key States:
| State | Standard SOL for Personal Injury | Notes |
|---|---|---|
| California | 2 years | From date of discovery |
| New York | 3 years | From date of injury or discovery |
| Texas | 2 years | From date of discovery |
| Florida | 2 years | Reduced from 4 years under 2023 law |
| Pennsylvania | 2 years | Host state for MDL |
| Illinois | 2 years | From date of injury discovery |
The discovery rule applies in most states. This means the clock starts when you knew or had reason to know your condition was caused by Ozempic.
Do not assume you have time. If you took Ozempic and suffered serious stomach injuries, the safest approach is to get a case evaluation immediately. A free consultation costs you nothing. Missing the deadline costs you everything.
Key Takeaway: Filing deadlines for the Ozempic lawsuit vary by state but typically run two to three years from the date you connected your injury to the drug, making early action in 2026 critical for many potential claimants.
Frequently Asked Questions
Is there a lawsuit against Ozempic right now?
Yes, there is an active lawsuit against Ozempic right now.
More than 10,000 individual cases have been filed in the federal MDL in the Eastern District of Pennsylvania.
The lawsuits allege that Ozempic caused serious gastrointestinal injuries including gastroparesis, and that Novo Nordisk failed to adequately warn patients.
Is there a class action lawsuit against Ozempic I can join?
The primary Ozempic lawsuit is a mass tort MDL, not a traditional class action.
This is actually better for seriously injured patients because compensation is based on individual injury severity rather than equal shares of a shared pot.
Some limited consumer protection class claims exist separately, but the main litigation track is the MDL.
What injuries qualify for the Ozempic lawsuit?
Gastroparesis, bowel obstruction, ileus, pulmonary aspiration, and cyclic vomiting syndrome are the primary qualifying injuries.
The injury must have been diagnosed by a doctor and documented in medical records.
Minor or temporary side effects like brief nausea do not meet the legal threshold for filing.
How much money could I get from an Ozempic lawsuit settlement?
Estimated settlements range from approximately $25,000 for milder cases to over $1 million for catastrophic injuries.
No official settlement fund has been announced as of 2026, so these are projections based on comparable pharmaceutical mass tort cases.
Your individual payout depends on the severity of your injury, your medical costs, and your lost income.
What is the filing deadline for the Ozempic lawsuit in 2026?
There is no single national deadline. Each state has its own statute of limitations, typically two to three years.
The clock usually starts running from the date you discovered or should have discovered that your injury was linked to Ozempic.
Getting a free case evaluation as soon as possible is the safest way to avoid missing your state’s specific deadline.
Where Things Go From Here
The Ozempic lawsuit is real, it is active, and 2026 is when it gets serious. Bellwether trials are expected to begin this year. Those outcomes will shape what tens of thousands of individual cases are worth.
If you took Ozempic or Wegovy and suffered from gastroparesis, stomach paralysis, bowel obstruction, or another serious gastrointestinal condition, your window to file may be closing. Statutes of limitations are already running for patients diagnosed in 2022 and 2023.
Get your medical records together. Find an MDL-registered attorney who handles pharmaceutical injury cases. Get a free case evaluation before the clock runs out.
